|
|
To see just what community-led health research can achieve, watch this video about Taurite Tū, a successful falls prevention exercise programme especially designed for Māori aged 50-plus and their whānau, supported by our Ngā Kanohi Kitea grants. For more information about our newly launched Ngā Kanohi Kitea Community Advancement Fund, see below.
|
|
1. Ngā Kanohi Kitea Community Advancement Fund now open
Our revamped Ngā Kanohi Kitea Community Advancement Fund provides an opportunity for iwi, hapū, other Māori organisations, and Māori researchers or research teams to undertake self-identified health research that can make a direct and significant difference to the health and wellbeing of their communities.
The following grants are available through the Ngā Kanohi Kitea Community Advancement Fund:
Ngā Kanohi Kitea Training Grant
This training grant provides funding support for individuals or groups looking to gain or develop skills, connections, or networks within a desired health research field.
Find out more about this grant and how to apply on HRC Gateway.
Ngā Kanohi Kitea Development Grant
The development grant provides funding for individuals, researchers, community groups or organisations to help prepare for undertaking a health research project or activity. This includes gathering information, developing connections and networks, or recruiting specialist expertise to support preparation for a larger research project or activity.
Find out more about this grant and how to apply on HRC Gateway.
Ngā Kanohi Kitea Project Grant
The project grant provides funding to support community-led research initiatives that address community-identified health and wellbeing needs. It can support collaboration or partnership with established and experienced research teams, or research organisations and larger institutions, provided the collaboration or partnership has been identified as a community priority and supports capability building and advancement of health and wellbeing within the community.
Find out more about this grant and how to apply on HRC Gateway.
Ngā Kanohi Kitea Knowledge Mobilisation Grant
This grant provides funding for iwi, hapū, other Māori community groups or organisations, Māori researchers or research teams who already have knowledge, evidence, or outcomes from research activities. The grant can support further translation, dissemination, or uptake of research findings.
Find out more about this grant and how to apply on HRC Gateway.
Applications for all four of these Ngā Kanohi Kitea grants close on 26 July at 1pm.
Unsure which Ngā Kanohi Kitea grant is right for you? Check out this flowchart to help you decide.
|
|
|
2. Apply for 2023 Project funding
Our 2023 Projects round is now open for registrations and Expressions of Interest on HRC Gateway, offering funding of up to $1.2 million for research projects that have the potential to vastly improve the health of New Zealanders. Projects can cover a diverse range of areas, from biomedical and public health to clinical studies, kaupapa Māori research, and Pacific health research.
In keeping with the evolving alignment of our investment opportunities and processes with the New Zealand Health Research Prioritisation Framework, we have made some key changes for 2023 Projects. These include:
- Introducing a ‘General’ category to replace the ‘Health and Wellbeing in New Zealand’ and ‘Improving Outcomes for Acute and Chronic Conditions in New Zealand’ research investment streams.
- The inclusion of a question about how your proposed research aligns to the Domains of the New Zealand Health Research Prioritisation Framework. Applicants are asked to consider which Domain the proposed research is most aligned with and identify this as the primary Domain. An additional secondary Domain can also be identified if relevant. While this information will not influence the assessment or selection of EOI proposals invited to submit full-stage proposals (and applicants will be able to change their domain selections in full-stage proposals), it is a good opportunity to think critically about where your research fits into the prioritisation framework in preparation for changes coming up over the next 12 months. We will be providing regular updates and signals about the changes we are making and what this means for you via Update and on our website.
As part of our focus on investing in people and creating more stable and sustainable career development opportunities, we are also encouraging early and mid-career researchers who have not previously been a first named investigator on a Project contract to apply as co-first named investigator in combination with a mentor/experienced researcher.
Key dates:
Registrations: opened 8 June and close on 6 July 2022 (1pm)
Expressions of Interest: opened on 8 June and close on 13 July 2022 (1pm)
Results available: 4 October 2022
Full applications: open 4 October 2022 (1pm) and close 16 November 2022 (1pm)
|
|
|
4. Update for 2022 Health Delivery applicants
The HRC's Health Delivery Project Expression of Interest (EOI) application outcomes are now available on HRC Gateway.
Due to unforeseen circumstances, we are not able to provide reviewer feedback for those EOI applications that are progressing to full stage. We will be able to provide feedback on those that have been declined, at a high level comparable with feedback provided in 2021, before the end of June.
Key dates for 2022 Health Delivery Research
Projects – Full stage
HRC Gateway full application open date: 8am, 9 June 2022
HRC Gateway full application submission deadline: 1pm, 28 July 2022
HRC Gateway rebuttal open date: 8am, 30 September 2022
HRC Gateway rebuttal submission deadline: 8am, 10 October 2022
Results available: 8am, 16 December 2022
Activation Grants and Career Development Awards
Round 1
Results available: 8am, 8 July 2022
Round 2
HRC Gateway application open date: 8am, 5 July 2022
HRC Gateway application submission deadline: 1pm, 1 September 2022
Results available: 8am, 16 December 2022
|
|
|
5. Members sought for the HRC's Standing Committee on Therapeutic Trials
Clinical trials that involve use of a new medicine require approval under Section 30 of the Medicines Act 1981. The Health Research Council's Standing Committee on Therapeutic Trials (SCOTT) undertakes scientific assessment of applications to conduct trials and makes recommendations to the Director-General of Health on whether or not trials should be approved.
The majority of applications reviewed by SCOTT are for clinical trials sponsored by the pharmaceutical industry. The review of an application is conducted by 3 to 4 members of SCOTT in a parallel process to the ethical review for clinical trials by Health and Disability Ethics Committees.
Role of SCOTT
The specific review of the safety, efficacy and scientific validity of the trial, and the competence of the investigators as indicated below:
1. To assess whether or not the proposed clinical trial of a medicine will provide clinically and scientifically useful information, particularly in relation to the safety and efficacy of the agent.
2. To assess the ability of the triallists to conduct the trial.
3. To review the trial design and the quality of clinical pharmacological research with particular respect to:
(a) power analysis and the need for triallists to satisfactorily justify their choice of numbers of subjects to be recruited to a trial
(b) efficacy and the need to establish criteria for clearly determining effectiveness of treatment
(c) toxicity.
What you will bring to the committee:
- Clinical pharmacologist or pharmaceutical background
- Extensive background in clinical research
The successful candidate(s) will be committed to equity in the context of Aotearoa New Zealand, particularly regarding our obligation under Te Tiriti o Waitangi to eliminate health inequity for Māori.
For a confidential discussion on the role, please contact Richard Robson, SCOTT chairperson at richard.robson@nzcr.co.nz
|
|
|
7. Conferences and events
Free webinar: Help me breathe - The RSV epidemic (*new date*)
29 June 2022
12.30pm, online
Thanks to everyone who registered for this webinar last month. Unfortunately, the webinar was postponed, but there is now a new date: 29 June 2022. Please click on the link below to register (note: you will need to re-register if you registered previously).
The key speakers for this webinar are Dr Emma Best, an expert in paediatric infectious diseases who will provide an overview of respiratory syncytial virus (RSV) in New Zealand; Dr Adrian Trenholme, a paediatrician who will talk about our progress towards RSV vaccination; and Dr Cass Byrnes, a paediatric respiratory specialist who will look at the long-term RSV outlook in Aotearoa.
The discussion will be chaired by Professor Stuart Dalziel, Cure Kids Chair of Child Health Research at the University of Auckland, and Professor Wayne Cutfield, Director of A Better Start National Science Challenge.
This webinar is free and open to anyone, but will be of particular interest to health professionals. It is hosted on Zoom and registration is essential.
The webinar is hosted by A Better Start E Tipu e Rea National Science Challenge, Cure Kids and The Paediatric Society of NZ.
Please note: Health professionals may use attendance at this webinar for continuing professional development points.
|
|
|
About Update
Update is a fortnightly e-newsletter about the health research sector, compiled and distributed by the Health Research Council of New Zealand. Short, topical items about health research funding, policy, activities, consultations, and publications are welcome. Please contact Suzy Botica, the HRC's senior communications advisor, for more details.
|
|
|
|
|
